La llamada de resultados del tercer trimestre de 2026 de Viridian Therapeutics abordó ingresos de 24,7 millones de dólares de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results